p53 gene alterations in special types of breast carcinoma: A molecular and immunohistochemical study in archival material
- 1 August 1995
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 176 (4) , 361-372
- https://doi.org/10.1002/path.1711760407
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Correlation of HER-2/neu Amplification With Expression and With Other Prognostic Factors in 1103 Breast CancersJNCI Journal of the National Cancer Institute, 1992
- Mutations in p53 as potential molecular markers for human breast cancer.Proceedings of the National Academy of Sciences, 1991
- Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression.Proceedings of the National Academy of Sciences, 1991
- Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosisBritish Journal of Cancer, 1990
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- A BamHI-polymorphism is detected by a genomic p53-clone (pBHP53)Nucleic Acids Research, 1989
- Chromosome 17 Deletions and p53 Gene Mutations in Colorectal CarcinomasScience, 1989
- The cellular oncogene p53 can be activated by mutagenesisNature, 1985
- The World Health Organization Histological Typing of Breast Tumors—Second EditionAmerican Journal of Clinical Pathology, 1982
- T antigen is bound to a host protein in SY40-transformed cellsNature, 1979